Kali, Inc. designs, markets, and distributes apparel and related products for 20-45 years old men under the VLOV brand name in the People’s Republic of China. The company sells its products to its distributors; and directly to consumers.

Average daily volume for KALY is 36 million shares. Today’s news has caused the volume to increase to 218 million shares in the morning hours of trading.

Kali, Inc. Press Release:

SARASOTA, Fla., Oct. 29, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali, Inc. (USOTC: KALY) today announced entering into discussions with Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to explore forming a joint venture company between the three to develop cannabis pharmaceutical products.  Kali recently announced a letter of intent to acquire NCM Biotech, the developer and owner of a patented cannabis extraction process – U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.”  Separately, Puration has licensed the NCM patent for use in specific commercial applications.  Nouveau has recently acquired a cannabis cultivation operation from Puration. In the joint venture, Kali would build on NCM’s medical research, and Puration’s commercial experience, combined with Nouveau’s plans to develop a proprietary pharmaceutical grade hemp cultivar, to together develop cannabis pharmaceutical products in partnerships with established pharmaceutical development companies. 

Frederick Ferri, CEO and Founder of NCM Biotech notes, “Some feedback has specifically indicated that a number of our candidate pharmaceutical products under development have a greater efficacy potential than GW Pharmaceutical[GWPH] products and candidate products.“

NCM Biotech’s medical advisory team includes John N. Gaitanis, MD., Director of Child Neurology at Tufts Medical Center/Floating Hospital for Children;  Lloyd R. Saberski, M.D., Associate Professor of Anesthesiology and Chronic Pain Management, Yale University, and John McMichael, Ph.D., President & CEO Beech Tree Labs.

Learn more about NCM Biotech at https://www.ncmbiotech.com/

Look for more info on Kali’s plans with NCM Biotech and Puration and Nouveau later this week in a management presentation on the company’s comprehensive post acquisition business plan.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company’s actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

Kali, Inc.


EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  EmergingGrowth.com, or its associates may have a position either long or short in any company mentioned herein. Please read our full disclosure, which can be found here, https://emerginggrowth.com/disclosure/. Please consult an investment professional before investing in anything viewed within this article or any other portion of EmergingGrowth.com. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.


Please enter your comment!
Please enter your name here